Related references
Note: Only part of the references are listed.Impact of anti-PEG antibody affinity on accelerated blood clearance of pegylated epoetin beta in mice
Tien-Ching Chang et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Linear Polyglycerol for N-terminal-selective Modification of Interleukin-4
Michael Tully et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
The Effect of Erythropoietin and Its Derivatives on Ischemic Stroke Therapy: A Comprehensive Review
Yuanyuan Ma et al.
FRONTIERS IN PHARMACOLOGY (2022)
Polymer selection impacts the pharmaceutical profile of site-specifically conjugated Interferon-?2a
Niklas Hauptstein et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Polyglycerols as Multi-Functional Platforms: Synthesis and Biomedical Applications
Paria Pouyan et al.
POLYMERS (2022)
Molecular Insights into Site-Specific Interferon-α2a Bioconjugates Originated from PEG, LPG, and PEtOx
Niklas Hauptstein et al.
BIOMACROMOLECULES (2021)
The evolution of polymer conjugation and drug targeting for the delivery of proteins and bioactive molecules
Antonella Grigoletto et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2021)
Polyglycerol for Half-Life Extension of Proteins-Alternative to PEGylation?
Michael Tully et al.
BIOMACROMOLECULES (2021)
Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies
Bing-Mae Chen et al.
ACS NANO (2021)
Progress and Challenges in PEGylated Proteins Downstream Processing: A Review of the Last 8 Years
Ana Mayela Ramos-de-la-Pena et al.
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2020)
Both IgM and IgG Antibodies against Polyethylene Glycol Can Alter the Biological Activity of Methoxy Polyethylene Glycol-Epoetin Beta in Mice
Tien-Ching Chang et al.
PHARMACEUTICS (2020)
Mammalian cell-free protein expression promotes the functional characterization of the tripartite non-hemolytic enterotoxin from Bacillus cereus
Franziska Ramm et al.
SCIENTIFIC REPORTS (2020)
The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation
Thai Thanh Hoang Thi et al.
POLYMERS (2020)
Anemia in patients of diabetic kidney disease
Shang-Feng Tsai et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2019)
Erythropoietin in tumor angiogenesis
Tiziana Annese et al.
EXPERIMENTAL CELL RESEARCH (2019)
Intracellular sensing of viral genomes and viral evasion
Hyun-Cheol Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Accelerating the Production of Druggable Targets: Eukaryotic Cell-Free Systems Come into Focus
Lena Thoring et al.
METHODS AND PROTOCOLS (2019)
Erythropoietin as a Neuroprotective Molecule: An Overview of Its Therapeutic Potential in Neurodegenerative Diseases
Federica Rey et al.
ASN NEURO (2019)
Cell-free protein synthesis as a novel tool for directed glycoengineering of active erythropoietin
Anne Zemella et al.
SCIENTIFIC REPORTS (2018)
Protein PEGylation for the design of biobetters: from reaction to purification processes
Joao Henrique Picado Madalena Santos et al.
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Cell-free synthesis of functional antibodies using a coupled in vitro transcription-translation system based on CHO cell lysates
M. Stech et al.
SCIENTIFIC REPORTS (2017)
Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population
Qi Yang et al.
ANALYTICAL CHEMISTRY (2016)
Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals
Bing-Mae Chen et al.
ANALYTICAL CHEMISTRY (2016)
Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
Peng Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?
Christian Lubich et al.
PHARMACEUTICAL RESEARCH (2016)
Head to Head Comparison of the Formulation and Stability of Concentrated Solutions of HESylated versus PEGylated Anakinra
Robert Liebner et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Safety Evaluation of Polyethylene Glycol (PEG) Compounds for Cosmetic Use
Hyun-Jun Jang et al.
TOXICOLOGICAL RESEARCH (2015)
Beyond Poly(ethylene glycol): Linear Polyglycerol as a Multifunctional Polyether for Biomedical and Pharmaceutical Applications
Anja Thomas et al.
BIOMACROMOLECULES (2014)
Cell-free eukaryotic systems for the production, engineering, and modification of scFv antibody fragments
Marlitt Stech et al.
ENGINEERING IN LIFE SCIENCES (2014)
Protein HESylation for half-life extension: Synthesis, characterization and pharmacokinetics of HESylated anakinra
Robert Liebner et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
Imaging of doxorubicin release from theranostic macromolecular prodrugs via fluorescence resonance energy transfer
Harald R. Krueger et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout
Peter E. Lipsky et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration
Amr S. Abu Lila et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Production of functional antibody fragments in a vesicle-based eukaryotic cell-free translation system
Marlitt Stech et al.
JOURNAL OF BIOTECHNOLOGY (2013)
IRES-Mediated Translation of Membrane Proteins and Glycoproteins in Eukaryotic Cell-Free Systems
Andreas K. Broedel et al.
PLOS ONE (2013)
Intravenous Administration of Polyethylene Glycol-Coated (PEGylated) Proteins and PEGylated Adenovirus Elicits an Anti-PEG Immunoglobulin M Response
Taro Shimizu et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Squaric Acid Mediated Synthesis and Biological Activity of a Library of Linear and Hyperbranched Poly(Glycerol)-Protein Conjugates
Frederik Wurm et al.
BIOMACROMOLECULES (2012)
Influence of architecture of high molecular weight linear and branched polyglycerols on their biocompatibility and biodistribution
Muhammad Imran ul-Haq et al.
BIOMATERIALS (2012)
Erythropoietin mimetic compound AGEM400(HES) binds to the same receptor as erythropoietin but displays a different spectrum of activities
Claudia Kessler et al.
CYTOKINE (2012)
Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents
Ricardo P. Garay et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Nanoparticle PEGylation for imaging and therapy
Jesse V. Jokerst et al.
NANOMEDICINE (2011)
Overcoming the PEG-addiction: well-defined alternatives to PEG, from structure-property relationships to better defined therapeutics
Matthias Barz et al.
POLYMER CHEMISTRY (2011)
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Katrin Knop et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Methoxy polyethylene glycol-epoetin beta - A review of its use in the management of anaemia associated with chronic kidney disease
Monique P. Curran et al.
DRUGS (2008)
Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients
Jonathan K. Armstrong et al.
CANCER (2007)
Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes
T Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Biocompatibility testing of branched and linear polyglycidol
RK Kainthan et al.
BIOMACROMOLECULES (2006)
Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products
C Fruijtier-Pölloth
TOXICOLOGY (2005)
Synthetic erythropoietic proteins: Tuning biological performance by site-specific polymer attachment
SY Chen et al.
CHEMISTRY & BIOLOGY (2005)
Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients
R Brunkhorst et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
The effect of polysialylation on the immunogenicity and antigenicity of asparaginase: implication in its pharmacokinetics
AI Fernandes et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2001)